Saturday 19 May 8 sessions
Sunday 20 May 41 sessions
Monday 21 May 40 sessions
Tuesday 22 May 38 sessions
Anna Ferrulli
Anna Ferrulli
OC6.2
Mon 21 12:00 Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
DEEP TRANSCRANIAL MAGNETIC STIMULATION ACUTELY MODULATES NEURO-ENDOCRINE PATHWAYS UNDERLYING OBESITY
Graham Roberts
Graham Roberts
UEM1.2
Sun 20 12:00 UEMS session - Session of the European Union of Medical Specialists Section of Endocrinology
ESE/UEMS European Board Examination in Endocrinology, Diabetes and Metabolism
Maeve Durkan
Maeve Durkan
UEM1.1
Sun 20 12:00 UEMS session - Session of the European Union of Medical Specialists Section of Endocrinology
News from Brussels
Christos Mantzoros
Christos Mantzoros
GH1
Sat 19 18:15 Geoffrey Harris Lecture - Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans
Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans
Filip Knop
Filip Knop
EJE1
Sat 19 18:50 EJE Prize Lecture - A gut feeling about glucagon
A gut feeling about glucagon
Philippe Bouchard
Philippe Bouchard
PL1
Sat 19 19:25 Plenary 1: Contraception: Past and future
Contraception: Past and future
Manuel Gahete
Manuel Gahete
MTBS1
Sun 20 08:00 Meet The Expert - Basic Scientist 1: Mouse models in endocrine tumors
Mouse models in endocrine tumors
Manuel Gahete
Manuel Gahete
S15.6
Mon 21 10:15 Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Invitation to EYES networking and annual meeting
Michal Kršek
Michal Kršek
MTE2
Sun 20 08:00 Meet The Expert 2 - Acromegaly: Optimal management after surgery
Acromegaly: Optimal management after surgery
Dirk Vanderschueren
Dirk Vanderschueren
MTE4
Sun 20 08:00 Meet The Expert 4 - Osteoporosis in men
Osteoporosis in men
Ana Maia
Ana Maia
MTE5
Sun 20 08:00 Meet The Expert 5 - Medullary thyroid cancer beyond surgery
Medullary thyroid cancer beyond surgery
Stravroula Kousteni
Stravroula Kousteni
PL2
Sun 20 09:15 Plenary 2 - Bone regulates the Brain
Bone regulates the Brain
Grigoris Effraimidis
Grigoris Effraimidis
S1.1
Sun 20 10:15 Symposium 1: Predicting events in autoimmune thyroid disease
The THEA score in familial thyroid dysfunction
Luca Chiovato
Luca Chiovato
S1.2
Sun 20 10:15 Symposium 1: Predicting events in autoimmune thyroid disease
IgG4 related thyroid autoimmune disease
Luca Chiovato
Luca Chiovato
D3.1
Mon 21 10:15 Debate 3: Subclinical hypothyroidism is a disease
FOR - Subclinical hypothyroidism is a disease
Milos Zarkovic
Milos Zarkovic
S1.3
Sun 20 10:15 Symposium 1: Predicting events in autoimmune thyroid disease
New scores for the prediction of Graves' disease
Ewout Hoorn
Ewout Hoorn
S2.1
Sun 20 10:15 Symposium 2: Salt and Sweet
Hyponatremia and mortality: moving beyond associations
Jonas Rutishauser
Jonas Rutishauser
S2.2
Sun 20 10:15 Symposium 2: Salt and Sweet
Hereditary Diabetes insipidus
Niels Grarup
Niels Grarup
S2.3
Sun 20 10:15 Symposium 2: Salt and Sweet
Sweet preference induced by FGF21
Hanns-Ulrich Marschall
Hanns-Ulrich Marschall
S3.1
Sun 20 10:15 Symposium 3: Bile Acid and Microbiota
Crosstalk between bile acids and intestinal microbiota - influence on host metabolism
Glenn. Gerhard
Glenn. Gerhard
S3.3
Sun 20 10:15 Symposium 3: Bile Acid and Microbiota
Bile acids and metabolic effects of bariatric surgery
Cheryl Walker
Cheryl Walker
S4.1
Sun 20 10:15 Symposium 4: Environmental Effects on Endocrine Function
Developmental Reprogramming of the Epigenome by Endocrine Disrupting Chemicals that Increase Cancer Risk
Malgorzata Trofimiuk-Müldner
Malgorzata Trofimiuk-Müldner
S4.2
Sun 20 10:15 Symposium 4: Environmental Effects on Endocrine Function
Iodine deficiency in pregnancy and development of offspring
Ana Sousa
Ana Sousa
S4.3
Sun 20 10:15 Symposium 4: Environmental Effects on Endocrine Function
Environmental contaminants and endocrine disruption: The story of obesogens
Noora Kotaja
Noora Kotaja
S5.1
Sun 20 10:15 Symposium 5: The role of sperm epigenome in fertility and inheritance
The quality control of the male germline transcriptome
Jörg Gromoll
Jörg Gromoll
S5.2
Sun 20 10:15 Symposium 5: The role of sperm epigenome in fertility and inheritance
Epigenetic germline mosaicism in infertile men
Tanya Vavouri
Tanya Vavouri
S5.3
Sun 20 10:15 Symposium 5: The role of sperm epigenome in fertility and inheritance
Mechanisms of epigenetic inheritance through sperm: lessons we have learnt from model organisms
Rachel Powell
Rachel Powell
N1.1
Sun 20 10:15 Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Good- Overview and Indications of Immunotherapy in Oncology
Sherwin Crisseno
Sherwin Crisseno
N1.3
Sun 20 10:15 Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Witty - The Role of Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathy
Inez Schoenmakers
Inez Schoenmakers
SS1.1
Sun 20 10:15 Special Symposium: Bone & Vitamin D
Free and bound vitamin D and health outcomes.
Karin Amrein
Karin Amrein
SS1.2
Sun 20 10:15 Special Symposium: Bone & Vitamin D
Vitamin D and Critical Care
Carlos Bernal-Mizrachi
Carlos Bernal-Mizrachi
SS1.3
Sun 20 10:15 Special Symposium: Bone & Vitamin D
Vitamin D, macrophages and atherosclerosis
Philippe Caron
Philippe Caron
OC1.1
Sun 20 12:00 Oral Communication: Benign thyroid diseases
Familial gestational hyperthyroidism caused by Val597Ile mutant of TSH receptor gene with human chorionic gonadotropin hypersensitivity
Beatriz Moreno
Beatriz Moreno
OC1.2
Sun 20 12:00 Oral Communication: Benign thyroid diseases
Relationship between TSH values in the first trimester of pregnancy and obstetric and neonatal complications
Marieke Snel
Marieke Snel
OC1.3
Sun 20 12:00 Oral Communication: Benign thyroid diseases
Thyroid hormone replacement therapy for subclinical hypothyroidism in adults: systematic review and meta-analysis of randomized-controlled trials
Malgorzata Trofimiuk-Muldner
Malgorzata Trofimiuk-Muldner
OC1.4
Sun 20 12:00 Oral Communication: Benign thyroid diseases
The Impact of Obligatory Iodine Prophylaxis on Thyroid Volume in Schoolchildren
João Neves
João Neves
OC1.5
Sun 20 12:00 Oral Communication: Benign thyroid diseases
Low free T3 levels within the reference range independently predict cardiovascular mortality in the general population
João Neves
João Neves
OC4.4
Sun 20 12:00 Oral Communication: Novel insights into prediabetes and type 2 diabetes
Association between prediabetes and incidence of chronic kidney disease, incident albuminuria, or worsening of kidney function: a secondary analysis of the SPRINT trial
Kai-Lun Hu
Kai-Lun Hu
OC2.2
Sun 20 12:00 Oral Communication: Look who is controlling your gonads!
Overexpressed kisspeptin/Kiss1R system in human granulosa cells may be involved in the pathogenesis of polycystic ovary syndrome (PCOS) by inhibiting ovulation.
Csilla Krausz
Csilla Krausz
OC2.3
Sun 20 12:00 Oral Communication: Look who is controlling your gonads!
Whole exome sequencing in non-obstructive azoospermia allows the identification of a high-risk subgroup of infertile men for undiagnosed Fanconi Anemia, a cancer-prone disease.
Violeta Heras
Violeta Heras
OC2.4
Sun 20 12:00 Oral Communication: Look who is controlling your gonads!
Novel Role of Central Ceramide Signaling in Mediating Obesity-Induced Precocious Puberty
Jayakumar Ambigapathy
Jayakumar Ambigapathy
OC2.5
Sun 20 12:00 Oral Communication: Look who is controlling your gonads!
Effect of thyroxine replacement on leydig cell and sertoli cell function in men with hypothyroidism
Peter Kamenický
Peter Kamenický
OC3.1
Sun 20 12:00 Oral Communication: New insights in bone disorders
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Burosumab, an Anti-FGF23 Antibody, In Adult X-Linked Hypophosphatemia (XLH)
Jérôme Frenette
Jérôme Frenette
OC3.2
Sun 20 12:00 Oral Communication: New insights in bone disorders
Can a bone protein protect against muscular dystrophy?
Karla Suchacki
Karla Suchacki
OC3.3
Sun 20 12:00 Oral Communication: New insights in bone disorders
[18F]-FDG PET/CT imaging: A tool to reveal the metabolic functions of bone marrow adipose tissue
Chantal Wiepjes
Chantal Wiepjes
OC3.5
Sun 20 12:00 Oral Communication: New insights in bone disorders
Change in bone mineral density during the first 10 years of gender affirming hormonal treatment in transwomen and transmen
Mercedes Rio-Moreno
Mercedes Rio-Moreno
OC4.1
Sun 20 12:00 Oral Communication: Novel insights into prediabetes and type 2 diabetes
Dietary intervention modulates the expression of the splicing machinery in patients at high-risk of type 2 diabetes development: clinical implications
Ioana Chisalita
Ioana Chisalita
OC4.2
Sun 20 12:00 Oral Communication: Novel insights into prediabetes and type 2 diabetes
Toe brachial index predicts major adverse cardiovascular events in patients with type 2 diabetes
Stella Bernardi
Stella Bernardi
OC4.3
Sun 20 12:00 Oral Communication: Novel insights into prediabetes and type 2 diabetes
Effects of TRAIL delivery on an experimental model of type 2 diabetes and diabetic nephropathy
Enric Sánchez
Enric Sánchez
OC4.5
Sun 20 12:00 Oral Communication: Novel insights into prediabetes and type 2 diabetes
The impact of prediabetes in lung function: data from the ILERVAS project
Tim Korevaar
Tim Korevaar
UEM1.3
Sun 20 12:00 UEMS session - Session of the European Union of Medical Specialists Section of Endocrinology
UEMS 3E Grant Presentation: Endocrine disruptors and thyroid function during pregnancy
Per Hellman
Per Hellman
D1.1
Sun 20 12:00 Debate 1 - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
For - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Michael Hauschild
Michael Hauschild
N2.1
Sun 20 12:00 Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Key Note Speaker: Principles and models of Transition – an overview
Irene Mitchelhill
Irene Mitchelhill
N2.2
Sun 20 12:00 Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Paediatric to adult transition in Endocrinology
Irene Mitchelhill
Irene Mitchelhill
N3.1
Mon 21 12:00 Meet the Nurse Expert & Case Discussions
Nursing Management of CAH: Education & Use of Multi-media Technology
Cristine Yedinak
Cristine Yedinak
N2.3
Sun 20 12:00 Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Transition between settings: hospital to community
Carsten Schultz
Carsten Schultz
NSA1
Sun 20 14:00 New Scientific Approach 1 - New tools for investigating insulin secretion
New tools for investigating insulin secretion
Eduardo Eyras
Eduardo Eyras
NSA2
Sun 20 14:00 New Scientific Approach 2 - The spliceosome as a target treatment of endocrine tumours
The spliceosome as a target treatment of endocrine tumours
Maria Zatelli
Maria Zatelli
D2.1
Sun 20 15:15 Debate 2 - Receptor profiling is useful for predicting pituitary therapy
For - Receptor profiling is useful for predicting pituitary therapy
Monica Marazulea
Monica Marazulea
D2.2
Sun 20 15:15 Debate 2 - Receptor profiling is useful for predicting pituitary therapy
Against - Receptor profiling is useful for predicting pituitary therapy
Jose. Florez
Jose. Florez
S6.1
Sun 20 15:15 Symposium 6: Precision Medicine for diabetes
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Leif Groop
Leif Groop
S6.2
Sun 20 15:15 Symposium 6: Precision Medicine for diabetes
Can genetics improve precision medicine in diabetes?
José Ordovas
José Ordovas
S6.3
Sun 20 15:15 Symposium 6: Precision Medicine for diabetes
Precision nutrition in obesity: gene - diet interaction
Stefan Groeneweg
Stefan Groeneweg
S7.1
Sun 20 15:15 Symposium 7: Expanding the spectrum of thyroid hormone use
TRIAC Trial in Allan-Herndon-Dudley-Syndrome (MCT8)
Kathrin Schmohl
Kathrin Schmohl
S7.2
Sun 20 15:15 Symposium 7: Expanding the spectrum of thyroid hormone use
Tetrac as an antiangiogenic agent in cancer
Paul Yen
Paul Yen
S7.3
Sun 20 15:15 Symposium 7: Expanding the spectrum of thyroid hormone use
New applications of thyroid hormones, analogs, and metabolites in non-alcoholic fatty liver
Fernando Rivadeneira
Fernando Rivadeneira
S8.2
Sun 20 15:15 Symposium 8: Bone fragility – from bench to clinic
What have we learnt from genome-wide association studies in osteoporosis
Lothar Seefried
Lothar Seefried
S8.3
Sun 20 15:15 Symposium 8: Bone fragility – from bench to clinic
Hypophosphatasia
Niels Jørgensen
Niels Jørgensen
S9.1
Sun 20 15:15 Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
Semen parameters as biomarkers of general health  
Eberhard Nieschlag
Eberhard Nieschlag
S9.2
Sun 20 15:15 Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
The Klinefelter syndrome: a challenge for endocrinologists 
Giovanni Corona
Giovanni Corona
S9.3
Sun 20 15:15 Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
Does "healthy obesity" exist in andrology? 
Marianne Pavel
Marianne Pavel
S10.2
Sun 20 15:15 Symposium 10: Hot topics in NETs
Treatment of small intestine and pancreatic NETs what and when?
Staffan Welin
Staffan Welin
S10.3
Sun 20 15:15 Symposium 10: Hot topics in NETs
Treatment update on carcinoid syndrome and carcinoid heart disease
Martin Fassnacht
Martin Fassnacht
GL1.1
Sun 20 15:15 European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Introduction to ENSAT Guidelines
Martin Fassnacht
Martin Fassnacht
GL1.5
Sun 20 15:15 European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Therapy of advanced ACC
Olaf Dekkers
Olaf Dekkers
GL1.2
Sun 20 15:15 European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Methods
Guillaume Assié
Guillaume Assié
GL1.3
Sun 20 15:15 European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Pathology & Prognostic factors
Massimo Terzolo
Massimo Terzolo
GL1.4
Sun 20 15:15 European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Adjuvant therapy
Harm Haak
Harm Haak
GL1.6
Sun 20 15:15 European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Special considerations on mitotane
Allan Herbison
Allan Herbison
PL3
Sun 20 17:15 Plenary 3 - The wonder world of GnRH neurons - cracking the pulse generator
The wonder world of GnRH neurons - cracking the pulse generator
Ilhan Satman
Ilhan Satman
MTE6
Mon 21 08:00 Meet The Expert 6 - Long term implications of hypoglycaemia in diabetes
Long term implications of hypoglycaemia in diabetes
Emese Mezosi
Emese Mezosi
MTE7
Mon 21 08:00 Meet The Expert 7 - Difficult cases of differentiated thyroid cancer
Difficult cases of differentiated thyroid cancer
Tina Dusek
Tina Dusek
MTE8
Mon 21 08:00 Meet The Expert 8 - Hormone replacement for the travelling patient
Hormone replacement for the travelling patient
Svetlana Vujovic
Svetlana Vujovic
MTE9
Mon 21 08:00 Meet The Expert 9 - Premature ovarian failure: an endocrine perspective
Premature ovarian failure: an endocrine perspective
Guy T'Sjoen
Guy T'Sjoen
MTE10
Mon 21 08:00 Meet The Expert 10 - Effects of gender-affirming hormone therapy on bone in transgender persons
Effects of gender-affirming hormone therapy on bone in transgender persons
Rafael Simo
Rafael Simo
PL4
Mon 21 08:45 Plenary 4 - The Retina as a Window for Exploring the Brain in Diabetes
The Retina as a Window for Exploring the Brain in Diabetes
Ilpo Huhtaniemi
Ilpo Huhtaniemi
EHM1
Mon 21 09:15 European Hormone Medal Lecture - Unraveling secrets of the hypothalami-pituitary-gonadal axis
Unraveling secrets of the hypothalamic-pituitary-gonadal axis
Carles Gaston-Massuet
Carles Gaston-Massuet
S11.1
Mon 21 10:15 Symposium 11: Novel aspects of Craniopharyngioma
Molecular Pathogenensis of Craniopharyngioma
Daniel Olsson
Daniel Olsson
S11.2
Mon 21 10:15 Symposium 11: Novel aspects of Craniopharyngioma
Bariatric Surgery as Treatment in Craniopharyngioma
Nicola Napoli
Nicola Napoli
S12.1
Mon 21 10:15 Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Increased fracture rate in diabetes and obesity      
Natasha Appelman
Natasha Appelman
S12.2
Mon 21 10:15 Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Bone quality evaluation in Pituitary diseases
Francesc Villarroya
Francesc Villarroya
S13.1
Mon 21 10:15 Symposium 13: The colours of fat
Brown adipose tissue as an endocrine organ
Florian Kiefer
Florian Kiefer
S13.2
Mon 21 10:15 Symposium 13: The colours of fat
Adipose Tissue Browning in Mice and Men
Pirjo Nuutila
Pirjo Nuutila
S13.3
Mon 21 10:15 Symposium 13: The colours of fat
Brown Adipose Tissue Imaging
Ulrich Boehm
Ulrich Boehm
S14.1
Mon 21 10:15 Symposium 14: Neuroendocrine basis of reproductive disorders
Developmental wiring of GnRH neurons
Jean-Pierre Hardelin
Jean-Pierre Hardelin
S14.2
Mon 21 10:15 Symposium 14: Neuroendocrine basis of reproductive disorders
Neuroendocrinology right from the nose: genetics and pathophysiology of the olfacto-genital syndrome (Kallmann syndrome)
Ruben Nogueiras
Ruben Nogueiras
S14.3
Mon 21 10:15 Symposium 14: Neuroendocrine basis of reproductive disorders
Metabolic-reproductive interactions: From bench to bedside
Ulla Feldt-Rasmussen
Ulla Feldt-Rasmussen
D3.2
Mon 21 10:15 Debate 3: Subclinical hypothyroidism is a disease
AGAINST - Subclinical hypothyroidism is a disease
Tatjana Isailovic
Tatjana Isailovic
S15.1
Mon 21 10:15 Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Introduction to EYES
Tatjana Isailovic
Tatjana Isailovic
OC11.3
Tue 22 11:30 Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Clinical and histopathological differences between MEN1 carriers and MEN1 phenocopy patients
Arkaitz Perez
Arkaitz Perez
S15.2
Mon 21 10:15 Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Metabolic reprogramming of cancer cells
Judith Favier
Judith Favier
S15.3
Mon 21 10:15 Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Epigenetic and metabolic reprogramming of SDH deficient pheochromocytomas and paragangliomas
Punith Kempegowda
Punith Kempegowda
S15.4
Mon 21 10:15 Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Immune Checkpoint Inhibitor Induced Hypophysitis – Experiences from the United Kingdom
Anna Angelousi
Anna Angelousi
S15.5
Mon 21 10:15 Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Alterations in Clock genes expression in human benign adrenal tumors
Didier Dewailly
Didier Dewailly
D4.1
Mon 21 12:00 Debate 4: AMH as the Primary Marker for Fertility
FOR - AMH as the Primary Marker for Fertility
Joop Laven
Joop Laven
D4.2
Mon 21 12:00 Debate 4: AMH as the Primary Marker for Fertility
AGAINST - AMH as the Primary Marker for Fertility
Tracy Williams
Tracy Williams
OC5.1
Mon 21 12:00 Oral Communication: Diving deep into adrenal cortex diseases
Is adrenal computed tomography accurate for the diagnosis of unilateral primary aldosteronism? A retrospective international cohort study
Guido Dalmazi
Guido Dalmazi
OC5.2
Mon 21 12:00 Oral Communication: Diving deep into adrenal cortex diseases
Steroid profiling by liquid chromatography tandem mass spectrometry in a large cohort of patients with adrenal incidentalomas
Isabel Weigand
Isabel Weigand
OC5.3
Mon 21 12:00 Oral Communication: Diving deep into adrenal cortex diseases
PRKACA L206R mutation in adrenal Cushing’s syndrome makes PKA RIIβ susceptible for caspase-mediated cleavage
Irina Chifu
Irina Chifu
OC5.4
Mon 21 12:00 Oral Communication: Diving deep into adrenal cortex diseases
Assessment of Tissue Sodium Content by 23Na-MRI in Patients with Adrenal Insufficiency – a Pilot Study
Isadora Cavalcante
Isadora Cavalcante
OC5.5
Mon 21 12:00 Oral Communication: Diving deep into adrenal cortex diseases
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Maxime Kwapich
Maxime Kwapich
OC6.3
Mon 21 12:00 Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
Visceral fat assessment in lamin A/C mutation carriers: Phenotype-Genotype correlation
Mesut Savas
Mesut Savas
OC6.4
Mon 21 12:00 Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
Anthropometric measurements and metabolic syndrome in relation to glucocorticoid receptor polymorphisms in (local) corticosteroid users
Rachida Rafiq
Rachida Rafiq
OC6.5
Mon 21 12:00 Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
Associations of different body fat deposits with serum 25-hydroxyvitamin D concentrations
Guillaume Assié
Guillaume Assié
OC7.1
Mon 21 12:00 Oral Communication: Genomic and clinical aspects of endocrine tumours
Molecular classification of benign adrenocortical tumors: an integrated genomic study
Irina Bancos
Irina Bancos
OC7.2
Mon 21 12:00 Oral Communication: Genomic and clinical aspects of endocrine tumours
Urine steroid metabolomics as a diagnostic tool for detection of adrenocortical malignancy – a prospective test validation study
E Buitenwerf
E Buitenwerf
OC7.5
Mon 21 12:00 Oral Communication: Genomic and clinical aspects of endocrine tumours
Randomized trial comparing phenoxybenzamine and doxazosine for preoperative treatment of patients with a pheochromocytoma (PRESCRIPT)
Patimat Khandaeva
Patimat Khandaeva
OC8.1
Mon 21 12:00 Oral Communication: MicroRNAs as biomarkers in endocrine diseases
Plasma microRNA expression in patients with Cushing’s disease differs from ACTH-ectopic Cushing’s syndrome.
Tais Assmann
Tais Assmann
OC8.2
Mon 21 12:00 Oral Communication: MicroRNAs as biomarkers in endocrine diseases
MicroRNA expression profiling and functional annotation analysis of their targets in patients with diabetic kidney disease.
J.C. Kralingen
J.C. Kralingen
OC8.3
Mon 21 12:00 Oral Communication: MicroRNAs as biomarkers in endocrine diseases
Circulating Levels of microRNAs Associate with Blood Pressure and Left Ventricular Mass in Primary Hypertensive Patients
Filippo Biscarini
Filippo Biscarini
OC8.4
Mon 21 12:00 Oral Communication: MicroRNAs as biomarkers in endocrine diseases
Detecting blood micro-RNAs and proteins associated with Graves’ disease and orbitopathy
Ines Foessl
Ines Foessl
OC8.5
Mon 21 12:00 Oral Communication: MicroRNAs as biomarkers in endocrine diseases
MicroRNA profiles in diabetic octogenarians with and without historical and prospective hip fractures
Cristian González-Guerrero
Cristian González-Guerrero
OC9.1
Mon 21 12:00 Oral Communication: Thyroid from basics to clinics
Increased urinary iodine precedes hypothyroidism in Dehal1 knockout mice
Sun Cho
Sun Cho
OC9.2
Mon 21 12:00 Oral Communication: Thyroid from basics to clinics
Anti-tumoral effects of metformin on metastatic bone lesions of thyroid cancer
Iva Jakubíková
Iva Jakubíková
OC9.3
Mon 21 12:00 Oral Communication: Thyroid from basics to clinics
A mouse model of BRAF V600E mutated papillary thyroid cancer imitating sporadic conditions
Mireia Jordà
Mireia Jordà
OC9.4
Mon 21 12:00 Oral Communication: Thyroid from basics to clinics
Identification of an epigenetic biomarker panel for predicting the development of distant metastases in differentiated thyroid cancer
Leo Guasti
Leo Guasti
NSA3
Mon 21 14:00 New Scientific Approach 3 - Re-Programming Strategies to Obtain Functional Endocrine Units
Re-Programming Strategies to Obtain Functional Endocrine Units
Garcilaso Riesco-Eizaguirre
Garcilaso Riesco-Eizaguirre
S16.1
Mon 21 15:15 Symposium 16: Changing practice in the management of thyroid neoplasms
Genomic alterations in thyroid malignancies
Murat Erdogan
Murat Erdogan
S16.2
Mon 21 15:15 Symposium 16: Changing practice in the management of thyroid neoplasms
Composite approach in the evaluation and management of thyroid nodule
Rossella Elisei
Rossella Elisei
S16.3
Mon 21 15:15 Symposium 16: Changing practice in the management of thyroid neoplasms
New classification and guidelines in differentiated thryroid cancers
Pierre Val
Pierre Val
S17.1
Mon 21 15:15 Symposium 17: Primary Adrenal Macronodular Hyperplasia
Adrenal development and benign tumor formation
Rossella Libe
Rossella Libe
S17.2
Mon 21 15:15 Symposium 17: Primary Adrenal Macronodular Hyperplasia
Genetics of Primary Adrenal Macronodular Hyperplasia: when and what to test
Dimitra Vassiliadi
Dimitra Vassiliadi
S17.3
Mon 21 15:15 Symposium 17: Primary Adrenal Macronodular Hyperplasia
Diagnosis and management of Primary Adrenal Macronodular Hyperplasia
Alessandra Gambineri
Alessandra Gambineri
S18.1
Mon 21 15:15 Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Sex hormones, obesity and type 2 diabetes – is there a link?
Mirjana Sumarac-Dumanovic
Mirjana Sumarac-Dumanovic
S18.2
Mon 21 15:15 Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Relevant therapies in PCOS
Jean Kaufman
Jean Kaufman
S18.3
Mon 21 15:15 Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Testosterone, obesity and the metabolic syndrome in males – do we need to replace steroids?
Giovanna Mantovani
Giovanna Mantovani
S19.1
Mon 21 15:15 Symposium 19: New Aspects of Pituitary Regulation
Cytoskeleton and pharmacologic resistance in pituitary tumours
Maria Malagon
Maria Malagon
S19.2
Mon 21 15:15 Symposium 19: New Aspects of Pituitary Regulation
What fat does with your pituitary
Frederique Albarel
Frederique Albarel
S19.3
Mon 21 15:15 Symposium 19: New Aspects of Pituitary Regulation
How cancer treatment effects your pituitary
Giovanni Ceccarini
Giovanni Ceccarini
S20.2
Mon 21 15:15 Symposium 20: All you need to know about lipodystrophy
Acquired forms of lipodystrophy
David Vilar
David Vilar
S20.3
Mon 21 15:15 Symposium 20: All you need to know about lipodystrophy
Lipodystrophies, diagnosis and treatment: a step-by-step approach
Beata Kos-Kudła
Beata Kos-Kudła
PW1.1
Mon 21 15:15 Publishing Workshop
Introduction from the Chair
Hans Romijn
Hans Romijn
PW1.2
Mon 21 15:15 Publishing Workshop
Responding to reviewer comments
Wouter Herder
Wouter Herder
PW1.3
Mon 21 15:15 Publishing Workshop
How to select your journal and submit your paper
Josef Köhrle
Josef Köhrle
PW1.5
Mon 21 15:15 Publishing Workshop
Data presentation, precision and ‘pseudoprecision’
Philip Yeoh
Philip Yeoh
N4.2
Mon 21 15:15 Nurses professional development, networking session and oral/poster presentations
Comparison of glucose, peak growth hormone & peak cortisol levels during insulin tolerance test with two different doses
Alina Rozanska
Alina Rozanska
N4.3
Mon 21 15:15 Nurses professional development, networking session and oral/poster presentations
Role of the Endocrine nurse in the MDT in improving care for patients with thyroid cancer
Marcela Xhindi
Marcela Xhindi
N4.4
Mon 21 15:15 Nurses professional development, networking session and oral/poster presentations
Influence of educational training course in improving knowledge of diabetes mellitus among nurses
Philippe Chanson
Philippe Chanson
CET1
Mon 21 17:15 Clinical Endocrinology Trust Lecture - Growth Hormone: not too much...not too less!
Growth Hormone: not too much...not to less!
Gerald Shulman
Gerald Shulman
PL5
Mon 21 17:45 Plenary 5: The link between insulin and fatty liver
The link between insulin and fatty liver
Carmen Georgescu
Carmen Georgescu
MTE11
Tue 22 08:00 Meet The Expert 11 - How to integrate PCSk9 inhibitors into hyperlipademia management
How to integrate PCSk9 inhibitors into hyperlipademia management
Gregory Kaltsas
Gregory Kaltsas
MTE12
Tue 22 08:00 Meet The Expert 12 - Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?
Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?
Mario Maggi
Mario Maggi
MTE13
Tue 22 08:00 Meet The Expert 13 - Erectile Dysfunction
Erectile Dysfunction
Stefan Pilz
Stefan Pilz
MTE14
Tue 22 08:00 Meet The Expert 14 - Vitamin D for everybody
Vitamin D for everybody?
Nigel Glynn
Nigel Glynn
MTE15
Tue 22 08:00 Meet The Expert 15 - Your emergency consult about hyponatraemia
Your emergency consult about hyponatraemia
Laszlo Hegedus
Laszlo Hegedus
PL6
Tue 22 08:45 Plenary 6: Does therapy for thyroid dysfunction decrease mortality?
Does therapy for thyroid dysfunction decrease mortality?
Duarte Pignatelli
Duarte Pignatelli
S21.1
Tue 22 09:45 Symposium 21: The Dance of Adrenal and Gonads
The interplay Between the Ovaries and Adrenals
Blazej Meczekalski
Blazej Meczekalski
S21.3
Tue 22 09:45 Symposium 21: The Dance of Adrenal and Gonads
Fertility in Congenital Adrenal Hyperplasia
Tim Schulz
Tim Schulz
S22.1
Tue 22 09:45 Symposium 22: The fatty bone
Marrow adipose tissue and skeletal health
William Cawthorn
William Cawthorn
S22.2
Tue 22 09:45 Symposium 22: The fatty bone
Bone marrow adipose tissue: starving for attention?
Peter Arner
Peter Arner
S22.3
Tue 22 09:45 Symposium 22: The fatty bone
Cross-talk between bone marrow and periperal adipose tissue in man
John Todd
John Todd
S23.1
Tue 22 09:45 Symposium 23: Pre-diabetes
What have we learnt so far about the immunogenetics of type 1 diabetes?
Anette Ziegler
Anette Ziegler
S23.2
Tue 22 09:45 Symposium 23: Pre-diabetes
Prevention and treatment of pre type 1 diabetes
Riccardo Bonadonna
Riccardo Bonadonna
S23.3
Tue 22 09:45 Symposium 23: Pre-diabetes
Treatment of pre type 2 diabetes
Riccarda Granata
Riccarda Granata
S24.2
Tue 22 09:45 Symposium 24: Ups and downs of hypothalamo-pituitary hormones
Peripheral Activities of Growth Hormone-Releasing Hormone (GHRH)
Niels Moeller
Niels Moeller
S24.3
Tue 22 09:45 Symposium 24: Ups and downs of hypothalamo-pituitary hormones
How Do Hypopituitary Patients Deal with Stress?
Francesc Borras
Francesc Borras
S25.1
Tue 22 09:45 Symposium 25: Late breaking
Microvesicles and exosomes: new players in metabolic diseases
Clemens Schmitt
Clemens Schmitt
S25.2
Tue 22 09:45 Symposium 25: Late breaking
Senescence-associated reprogramming promotes cancer stemness
Daniel Kaplan
Daniel Kaplan
S25.3
Tue 22 09:45 Symposium 25: Late breaking
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor
Brigitte Velkeniers
Brigitte Velkeniers
D5.2
Tue 22 09:45 Debate 5: Pregnant women should be screened for thyroid hormones and antibodies
AGAINST - Pregnant women should be screened for thyroid hormones and antibodies
Alberto Pereira
Alberto Pereira
Tue 22 09:45 Endo-ERN: concrete examples of added value for patient care
Introduction, structure, and virtual consultation using the EU-ERN CPMS
Olaf Hiort
Olaf Hiort
Tue 22 09:45 Endo-ERN: concrete examples of added value for patient care
Caring for endocrinology across the life span: DSD and Hypogonadotropic hypogonadism
Mrs Manuela Brösamle
Mrs Manuela Brösamle
Tue 22 09:45 Endo-ERN: concrete examples of added value for patient care
Patient and family perspectives
Nicolás Olea
Nicolás Olea
D6.1
Tue 22 11:30 Debate 6: Endocrine disruptors: Regulatory vs. Scientific Perspectives
SCIENCE - Endocrine disruptors: Regulatory vs. Scientific Perspectives
Sharon Munn
Sharon Munn
D6.2
Tue 22 11:30 Debate 6: Endocrine disruptors: Regulatory vs. Scientific Perspectives
REGULATORY - Endocrine disruptors: Regulatory vs. Scientific Perspectives
Jakob Skov
Jakob Skov
OC10.1
Tue 22 11:30 Oral Communication: Cardiovascular aspects of endocrine diseases
Glucocorticoid replacement-doses and cardiovascular events in autoimmune Addison’s disease – a population based retrospective cohort study.
Mihail Zilbermint
Mihail Zilbermint
OC10.3
Tue 22 11:30 Oral Communication: Cardiovascular aspects of endocrine diseases
ARMC5 variants and risk of hypertension in African Americans: Minority Health-GRID study
Inés Jimenez
Inés Jimenez
OC10.4
Tue 22 11:30 Oral Communication: Cardiovascular aspects of endocrine diseases
Improvement in the control of hypertension in diabetic patients screened for hyperaldosteronism
Michal Gershinsky
Michal Gershinsky
OC10.5
Tue 22 11:30 Oral Communication: Cardiovascular aspects of endocrine diseases
Increased Risk of Antithyroid Drug-induced Agranulocytosis with Amiodarone
Anne Jouinot
Anne Jouinot
OC11.2
Tue 22 11:30 Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Molecular classifiers refine the prognostic stratification of adrenocortical carcinoma
Silviu Sbiera
Silviu Sbiera
OC11.4
Tue 22 11:30 Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Update in the genetic landscape of Cushing’s Disease: TP53 and a new deubiquitinase in spotlight
Elisa Sala
Elisa Sala
OC11.5
Tue 22 11:30 Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Natural history of Rathke’s Cleft Cysts: a multicenter experience
Renata Frazao
Renata Frazao
OC12.1
Tue 22 11:30 Oral Communication: Novel aspects of puberty development and Cushing's disease
Growth hormone signaling in leptin receptor expressing cells, but not in Kiss1 expressing neurons, regulates the timing of puberty
Małgorzata Kałużna
Małgorzata Kałużna
OC12.2
Tue 22 11:30 Oral Communication: Novel aspects of puberty development and Cushing's disease
Oligogenicity in Kallmann syndrome - an underestimated phenomenon?
Biagio Cangiano
Biagio Cangiano
OC12.3
Tue 22 11:30 Oral Communication: Novel aspects of puberty development and Cushing's disease
Evaluation of genetic predisposition in severe and mild phenotypes of isolated hypogonadotropic hypogonadism
Andre Lacroix
Andre Lacroix
OC12.4
Tue 22 11:30 Oral Communication: Novel aspects of puberty development and Cushing's disease
Late-night salivary cortisol (LNSC) levels in a Phase III study of long-­acting pasireotide in patients with Cushing’s disease (CD)
Elena Valassi
Elena Valassi
OC12.5
Tue 22 11:30 Oral Communication: Novel aspects of puberty development and Cushing's disease
Diabetes mellitus and muscle weakness are independently associated with mortality in patients with Cushing's syndrome. Data from ERCUSYN.
Mark Postma
Mark Postma
OC13.1
Tue 22 11:30 Oral Communication: The curious case of growth hormone
Postoperative use of somatostatin analogs and mortality in patients with acromegaly.
Simona Galoiu
Simona Galoiu
OC13.2
Tue 22 11:30 Oral Communication: The curious case of growth hormone
Time trends of mortality in patients with GH secreting and non-functioning pituitary adenoma.
Manuel Puig-Domingo
Manuel Puig-Domingo
OC13.3
Tue 22 11:30 Oral Communication: The curious case of growth hormone
Molecular profiling for assistance to pharmacological treatment of acromegaly
Tiziana Feola
Tiziana Feola
OC13.4
Tue 22 11:30 Oral Communication: The curious case of growth hormone
Effects of Pegvisomant on Glucose Metabolism in Acromegaly: A Meta-analysis of Prospective Interventional Studies
Isadora Furigo
Isadora Furigo
OC13.5
Tue 22 11:30 Oral Communication: The curious case of growth hormone
Growth hormone acts in AGRP neurons to control energy expenditure during food restriction and promotes counter-regulatory responses to hypoglycemia via the ventromedial hypothalamus
Anna Papadopoulou
Anna Papadopoulou
OC14.2
Tue 22 11:30 Oral Communication: What is new in gestational and type 1 diabetes?
Profiling of activation patterns of placental mTOR in pregnancies complicated by gestational diabetes mellitus
Francesco Tecilazich
Francesco Tecilazich
OC14.3
Tue 22 11:30 Oral Communication: What is new in gestational and type 1 diabetes?
Patrolling monocytes are activated in diabetes and provide protection to retinal vessels in the context of leukostasis.
Maria Rotkank
Maria Rotkank
OC14.4
Tue 22 11:30 Oral Communication: What is new in gestational and type 1 diabetes?
The variability of glycemia and the metabolic composition of brain cells in patients with type 1 diabetes mellitus
Albert Cano
Albert Cano
OC14.5
Tue 22 11:30 Oral Communication: What is new in gestational and type 1 diabetes?
Type 1 diabetes mellitus: defining the best cut-off points of arterial stiffness for predicting cardiovascular risk according to the Steno Type 1 Risk Engine
Peter Igaz
Peter Igaz
NSA5
Tue 22 13:30 New Scientific Approach 5 - Circulating miRNAs in Endocrine Tumours
Circulating miRNAs in Endocrine Tumours
Sabine Costagliola
Sabine Costagliola
NSA6
Tue 22 13:30 New Scientific Approach 6 - Functional thyroid in the dish
Functional thyroid in the dish
Laura Ramírez
Laura Ramírez
S26.1
Tue 22 14:45 Symposium 26: Cortisol: Too much of a Good Thing
Genetics of Cushing's disease
Nicolaas Wee
Nicolaas Wee
S26.2
Tue 22 14:45 Symposium 26: Cortisol: Too much of a Good Thing
Hypercortisolism and the Brain
Krystallenia Alexandraki
Krystallenia Alexandraki
S26.3
Tue 22 14:45 Symposium 26: Cortisol: Too much of a Good Thing
Differentiating Cushing from Pseudo-Cushing
Thomas Clemens
Thomas Clemens
S27.1
Tue 22 14:45 Symposium 27: Emerging treatments in osteoporosis
Molecular basis of bone anabolism
Tilman Rachner
Tilman Rachner
S27.2
Tue 22 14:45 Symposium 27: Emerging treatments in osteoporosis
Novel therapies: PTH-related protein and sclerostin inhibition
Zhanna Belaya
Zhanna Belaya
S27.3
Tue 22 14:45 Symposium 27: Emerging treatments in osteoporosis
Sequential and combination therapy for osteoporosis
Michal Lotem
Michal Lotem
S28.1
Tue 22 14:45 Symposium 28: Endocrinology Meets Immunology
Concept of Immunotherapy in Cancer
Efisio Puxeddu
Efisio Puxeddu
S28.2
Tue 22 14:45 Symposium 28: Endocrinology Meets Immunology
Immunotherapy for Thyroid Carcinoma
Balázs Gereben
Balázs Gereben
S29.1
Tue 22 14:45 Symposium 29: Thyroid hormone action: regulation and clinical implications
Tissue-specific regulation of thyroid hormone action
Annette Grüters-Kieslich
Annette Grüters-Kieslich
S29.3
Tue 22 14:45 Symposium 29: Thyroid hormone action: regulation and clinical implications
Elevated TSH in Children
Lina Michala
Lina Michala
S30.1
Tue 22 14:45 Symposium 30: Disorders of Sexual Development (DSD)
Long term consequences of Disorders of Sexual Development
Nicolas Kalfa
Nicolas Kalfa
S30.2
Tue 22 14:45 Symposium 30: Disorders of Sexual Development (DSD)
Atypical Genital Development and Hypospadias: a Pediatric Urology perspective from Etiology to Surgery
Julie Bakker
Julie Bakker
S30.3
Tue 22 14:45 Symposium 30: Disorders of Sexual Development (DSD)
Gender Dysphoria and Brain Function
Manuel Serrano
Manuel Serrano
PL7
Tue 22 17:15 Plenary 7: Metabolic control of longevity
Metabolic control of longevity
Dr John Newell-Price
John Newell-Price
MTE16
Tue 22 08:00 Meet The Expert 16 - Adrenal incidentaloms
Adrenal incidentaloms
Dr. Kristien Boelaert
Kristien Boelaert
D5.1
Tue 22 09:45 Debate 5: Pregnant women should be screened for thyroid hormones and antibodies
FOR - Pregnant women should be screened for thyroid hormones and antibodies
Nikolaos Nikolaou
Nikolaos Nikolaou
OC6.1
Mon 21 12:00 Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
5β-reductase (AKR1D1) is a potent regulator of hepatic insulin sensitivity, carbohydrate and lipid metabolism in vitro and in vivo
Dr. Niki Karavitaki
Niki Karavitaki
N1.2
Sun 20 10:15 Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Bad - Immunotherapy-induced Endocrinopathy
Outi Mäkitie
Outi Mäkitie
S8.1
Sun 20 15:15 Symposium 8: Bone fragility – from bench to clinic
Clinical spectrum of new monogenic forms of osteoporosis
Karine Rizzoti
Karine Rizzoti
MTEBS2
Mon 21 08:00 Meet the Expert - Basic Scientist 2 -Single-cell sequencing in endocrine diseases
Single-cell sequencing in endocrine diseases
Patrice Mollard
Patrice Mollard
S24.1
Tue 22 09:45 Symposium 24: Ups and downs of hypothalamo-pituitary hormones
How Does Pituitary Release its Hormones?
Helen Spoudeas
Helen Spoudeas
S11.3
Mon 21 10:15 Symposium 11: Novel aspects of Craniopharyngioma
Psychosocial dysfunction after treatment of of Craniopharyngioma
Taneli Raivio
Taneli Raivio
MTE3
Sun 20 08:00 Meet The Expert 3 - Managing delayed puberty
Managing delayed puberty
Paolo Giacobini
Paolo Giacobini
NSA4
Mon 21 14:00 New Scientific Approach 4 - 3D visualisation of the HPG axis in mice and humans
3D visualisation of the HPG axis in mice and humans
Cristina Ronchi
Cristina Ronchi
OC11.1
Tue 22 11:30 Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Targeted molecular analysis in adrenocortical carcinomas: a way towards improved personalized prognostication.​
Lisa Owens
Lisa Owens
OC2.1
Sun 20 12:00 Oral Communication: Look who is controlling your gonads!
The in vivo and in vitro effects of kisspeptin on human ovarian function
Lars Moeller
Lars Moeller
MTBS3
Tue 22 08:00 Meet The Expert - Basic Scientist 3: Watch out for noncanonical mechanisms of thyroid hormone action!
Watch out for noncanonical mechanisms of thyroid hormone action!
David Savage
David Savage
S20.1
Mon 21 15:15 Symposium 20: All you need to know about lipodystrophy
Insights in the pathogenesis of lipodystrophy
Dr Scott Akker
Scott Akker
S21.2
Tue 22 09:45 Symposium 21: The Dance of Adrenal and Gonads
Management of phaeochromocytoma during pregnancy
Jaap Deinum
Jaap Deinum
D1.2
Sun 20 12:00 Debate 1 - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Against - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Diana Heemst
Diana Heemst
S29.2
Tue 22 14:45 Symposium 29: Thyroid hormone action: regulation and clinical implications
Thyroid hormone economy in human aging
Mark Vanderpump
Mark Vanderpump
S28.3
Tue 22 14:45 Symposium 28: Endocrinology Meets Immunology
Immunotherapy Related Endocrinopathies
Sof Andrikopoulos
Sof Andrikopoulos
PW1.4
Mon 21 15:15 Publishing Workshop
Publishing ethics
Laura Gathercole
Laura Gathercole
S3.2
Sun 20 10:15 Symposium 3: Bile Acid and Microbiota
5β-reductase, bile acid synthesis, and the control of energy metabolism
Sabrina Corbetta
Sabrina Corbetta
OC7.3
Mon 21 12:00 Oral Communication: Genomic and clinical aspects of endocrine tumours
IncRNAs profiling reveals epigenetic heterogeneity among human parathyroid tumor
Kristina Chen
Kristina Chen
OC3.4
Sun 20 12:00 Oral Communication: New insights in bone disorders
Renal function change in chronic hypoparathyroidism patients treated with recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and in a historical control cohort treated with standard therapy
Narjes Nasiri-Ansari
Narjes Nasiri-Ansari
OC10.2
Tue 22 11:30 Oral Communication: Cardiovascular aspects of endocrine diseases
Canagliflozin attenuates the progression of atherosclerosis via reducing hyperlipidaemia and inflammation process in ApoE KO Mice
Sofia Llahana
Sofia Llahana
N2.4
Sun 20 12:00 Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Transition in Hypogonadism
Sofia Llahana
Sofia Llahana
N4.1
Mon 21 15:15 Nurses professional development, networking session and oral/poster presentations
Welcome and update on ESE nurse activties
Jens Bollerslev
Jens Bollerslev
S12.3
Mon 21 10:15 Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Effect of parathyroid dysfunction on incidence of bone fractures
Alexandre Buffet
Alexandre Buffet
OC7.4
Mon 21 12:00 Oral Communication: Genomic and clinical aspects of endocrine tumours
Germline mutations in the mitochondrial 2-oxoglutarate/malate carrier (SLC25A11) gene confer predisposition to metastatic paragangliomas.